Aristotle Capital Boston’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.6M Sell
165,939
-10,737
-6% -$1.41M 1.22% 24
2025
Q4
$21M Buy
176,676
+27,791
+19% +$3.16M 1.15% 28
2025
Q3
$14.9M Buy
148,885
+26,229
+21% +$3.12M 0.77% 58
2025
Q2
$15.8M Sell
122,656
-6,859
-5% -$835K 0.81% 46
2025
Q1
$16.6M Sell
129,515
-22,140
-15% -$3.18M 0.83% 47
2024
Q4
$23.2M Sell
151,655
-18,299
-11% -$3.1M 0.86% 47
2024
Q3
$30.4M Buy
169,954
+1,219
+0.7% +$212K 1.01% 40
2024
Q2
$27.5M Sell
168,735
-3,829
-2% -$621K 0.93% 42
2024
Q1
$30.2M Sell
172,564
-1,067
-0.6% -$175K 0.92% 43
2023
Q4
$29.2M Buy
173,631
+2,475
+1% +$361K 0.89% 46
2023
Q3
$24.6M Sell
171,156
-9,755
-5% -$1.59M 0.79% 52
2023
Q2
$33.3M Buy
180,911
+2,204
+1% +$361K 1% 39
2023
Q1
$28.4M Buy
178,707
+1,668
+0.9% +$256K 0.88% 47
2022
Q4
$24.1M Sell
177,039
-3,400
-2% -$476K 0.76% 56
2022
Q3
$20.9M Sell
180,439
-8,670
-5% -$1.18M 0.71% 58
2022
Q2
$22.9M Buy
189,109
+9,078
+5% +$1.14M 0.68% 59
2022
Q1
$25.6M Sell
180,031
-6,734
-4% -$956K 0.65% 69
2021
Q4
$32.9M Sell
186,765
-1,803
-1% -$301K 0.77% 54
2021
Q3
$29.1M Sell
188,568
-29,920
-14% -$4.35M 0.68% 65
2021
Q2
$29.4M Sell
218,488
-68,134
-24% -$9.17M 0.67% 64
2021
Q1
$37.8M Sell
286,622
-6,102
-2% -$802K 0.84% 45
2020
Q4
$34.6M Sell
292,724
-84,295
-22% -$9.83M 0.82% 43
2020
Q3
$39.7M Buy
377,019
+4,674
+1% +$494K 1.15% 24
2020
Q2
$39.8M Buy
372,345
+41,002
+12% +$3.81M 1.21% 28
2020
Q1
$26.5M Sell
331,343
-54,323
-14% -$4.85M 1.13% 29
2019
Q4
$34.1M Buy
385,666
+23,931
+7% +$2.06M 0.94% 39
2019
Q3
$29.6M Buy
361,735
+11,200
+3% +$910K 0.87% 47
2019
Q2
$33.1M Buy
350,535
+12,197
+4% +$1.04M 1.03% 33
2019
Q1
$28.7M Buy
338,338
+134,650
+66% +$10.1M 0.96% 40
2018
Q4
$12.8M Buy
203,688
+26,141
+15% +$1.69M 1.05% 37
2018
Q3
$12.1M Sell
177,547
-30,085
-14% -$2.11M 0.89% 53
2018
Q2
$12.9M Sell
207,632
-9,243
-4% -$565K 1.03% 43
2018
Q1
$11.3M Buy
216,875
+51,646
+31% +$2.83M 0.53% 80
2017
Q4
$8.26M Sell
165,229
-106,249
-39% -$5.18M 0.6% 77
2017
Q3
$11.8M Sell
271,478
-85,046
-24% -$3.31M 1.06% 31
2017
Q2
$12.8M Sell
356,524
-80,136
-18% -$2.54M 1.43% 18
2017
Q1
$11.6M Buy
436,660
+50,311
+13% +$1.23M 1.55% 15
2016
Q4
$8.11M Sell
386,349
-10,538
-3% -$201K 1.11% 31
2016
Q3
$6.89M Buy
396,887
+15,139
+4% +$249K 1.23% 29
2016
Q2
$5.78M Buy
+381,748
New +$5.87M 1.12% 33

Other funds holding NOVT

Aristotle Capital Boston's NOVT Position: Q1 2026 in Review

Aristotle Capital Boston reduced its Novanta (NOVT) stake by 6.1% in Q1 2026, selling an estimated $1.41M and leaving 165,939 shares worth $19.6M. The position accounts for 1.22% of the portfolio, ranked #24.

Aristotle Capital Boston first reported a position in NOVT in Q2 2016 and has held it in 40 quarters since. The position peaked at $39.8M in Q2 2020. 329 funds tracked by Wall St. Rank hold NOVT as of Q1 2026.

  • Aristotle Capital Boston held 165,939 shares of Novanta worth $19.6M as of Q1 2026.
  • Aristotle Capital Boston sold 10,737 Novanta shares in Q1 2026, an estimated $1.41M.
  • Novanta made up 1.22% of Aristotle Capital Boston's portfolio in Q1 2026, its #24 holding.
  • Aristotle Capital Boston first reported a position in Novanta in Q2 2016 and has held it in 40 quarters since.
  • Aristotle Capital Boston's Novanta position peaked at $39.8M in Q2 2020.
  • 329 funds tracked by Wall St. Rank held Novanta as of Q1 2026.

Based on Aristotle Capital Boston's 13F filing for Q1 2026, filed 15 May 2026.